Siegfried Holding Management

Management criteria checks 2/4

Siegfried Holding's CEO is Marcel Imwinkelried, appointed in Jan 2024, has a tenure of 1.33 years. total yearly compensation is CHF2.00M, comprised of 32.1% salary and 67.9% bonuses, including company stock and options. directly owns 0.011% of the company’s shares, worth CHF477.84K. The average tenure of the management team and the board of directors is 1.7 years and 5.1 years respectively.

Key information

Marcel Imwinkelried

Chief executive officer

CHF 2.0m

Total compensation

CEO salary percentage	32.12%
CEO tenure	1.3yrs
CEO ownership	0.01%
Management average tenure	1.7yrs
Board average tenure	5.1yrs

Recent management updates

No updates

Recent updates

No updates

CEO Compensation Analysis

How has Marcel Imwinkelried's remuneration changed compared to Siegfried Holding's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2024	CHF 2m	CHF 643k	CHF 160m

Compensation vs Market: Marcel's total compensation ($USD2.44M) is about average for companies of similar size in the Swiss market ($USD2.00M).

Compensation vs Earnings: Insufficient data to compare Marcel's compensation with company performance.

CEO

Marcel Imwinkelried (57 yo)

1.3yrs

Tenure

CHF 2,002,862

Compensation

Mr. Marcel Imwinkelried serves as Chief Executive Officer at Siegfried Holding AG from 2024 and serves as its COO Drug Products ad interim since 2024 and was its Chief Operating Officer of Drug Products fr...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Marcel Imwinkelried	CEO & COO Drug Products ad interim	1.3yrs	CHF 2.00m	0.011% CHF 477.8k
Reto Suter	Chief Financial Officer	8yrs	no data	0.34% CHF 14.3m
Stefan Randl	Chief Scientific Officer	less than a year	no data	no data
Luca Torre	Chief Legal & Sustainability Officer	6.3yrs	no data	no data
Peter Stierli	Head of Corporate Communications	no data	no data	no data
Olesia Silanteva	Chief Human Resources Officer	less than a year	no data	no data
Marianne Spane	Chief Business Officer of Drug Substances & Drug Products	4.3yrs	no data	0.65% CHF 27.3m
Enno Schweinberger	Head Global Quality Management DS - Zofingen	no data	no data	no data
Beatrice Harder	Head Regulatory Affairs - Site Zofingen	no data	no data	no data
John Jones	Head of Operations - Malta	no data	no data	no data
Florent Trouillet	Head Corporate Quality Systems - Global Quality Systems	no data	no data	no data
Henrik Krupper	Chief Operating Officer Drug Substances	1.7yrs	no data	no data

1.7yrs

Average Tenure

53yo

Average Age

Experienced Management: 142932682's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Andreas Casutt	Independent Non-Executive Chairman	15.1yrs	CHF 484.32k	0.46% CHF 19.4m
Isabelle Welton	Independent Non-Executive Director	5.1yrs	CHF 227.47k	0.025% CHF 1.0m
Wolfram Carius	Independent Non-Executive Director	11.3yrs	CHF 221.25k	0.083% CHF 3.5m
Martin Schmid	Independent Non-Executive Vice Chairman	9.3yrs	CHF 253.79k	0.060% CHF 2.5m
Beat Walti	Independent Director	3.1yrs	CHF 222.20k	0.012% CHF 493.3k
Elodie Carr-Cingari	Director	2.1yrs	CHF 227.38k	0.0080% CHF 332.6k
Alexandra Brand	Independent Director	3.1yrs	CHF 216.94k	0.012% CHF 493.3k

5.1yrs

Average Tenure

56yo

Average Age

Experienced Board: 142932682's board of directors are considered experienced (5.1 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/25 22:35
End of Day Share Price	2025/04/25 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Siegfried Holding AG is covered by 22 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Leonildo Delgado	Baader Helvea Equity Research
Volker Bosse	Baader Helvea Equity Research
Thomas Meyer	Baader Helvea Equity Research